BridgeMD
New treatment option for Neurodevelopmental Disorder (Diagnosis)
Official title Feeding Disorders in Children
ClinicalTrials.gov ID: NCT07431671
What this study is testing
- What it's testing
- Pediatric Feeding Disorders (PFDs) are conditions characterized by persistent difficulties in food intake, commonly manifesting as food selectivity, food refusal, and dysfunctional mealtime behaviors. Their prevalence in the general pediatric population ranges from 3% to 10%, with substantially higher rates reported among children with neurodevelopmental disorders.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 7
You may be able to join if
- Age between 2 and 7 years.
- Diagnosis of a neurodevelopmental disorder according to DSM-5 criteria.
- Presence of a feeding disorder.
You likely can't join if
- Presence of respiratory, cardiovascular, gastrointestinal, or neurological conditions preventing oral feeding.
- Insufficient caregiver proficiency in the Italian language, such as to compromise completion of the questionnaires.
- Children who are undergoing a different feeding intervention at the time of screening.
The study team makes the final eligibility decision.
Where it's taking place
- Roma, RM, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 7 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Roma, RM, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.